Caplin Point Laboratories Ltd has informed BSE that in connection with the approval of the Companys state of art sterile injectable facility (Unit IV) under European GMP, the Officials of EU GMP had carried out inspection of the unit recently. The outcome of the inspection is very positive and it is likely that the approval may be accorded shortly. The Company shall update upon receipt of the final communication from the said Authorities.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
